Increased awareness is PAD 'call to action'. (Market Updates).

A call to action to increase the awareness, detection and treatment of peripheral arterial disease (PAD) among healthcare professionals was published last month in the Archives of Internal Medicine by the Prevention of Atherothrombotic Disease Network, an independent, international, multidisciplinary group of specialists supported by a grant from the Sanofi-Synthelabo/Bristol-Myers Squibb Pharmaceuticals Partnership. PAD is characterized by arterial stenosis and occlusions in the peripheral arterial bed. It can be symptomatic or asymptomatic, with symptomatic PAD ranging in severity from intermittent claudication (IC) to critical limb ischemia.

Regardless of symptomology, PAD …